Teacher Retirement System of Texas Has $5.02 Million Holdings in Encompass Health Corporation $EHC

Teacher Retirement System of Texas decreased its position in shares of Encompass Health Corporation (NYSE:EHC) by 33.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,953 shares of the company’s stock after selling 20,352 shares during the quarter. Teacher Retirement System of Texas’ holdings in Encompass Health were worth $5,022,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Pinnacle Wealth Planning Services Inc. increased its holdings in shares of Encompass Health by 4.0% during the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock valued at $263,000 after acquiring an additional 99 shares in the last quarter. Securian Asset Management Inc. increased its holdings in shares of Encompass Health by 1.3% during the second quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock valued at $946,000 after acquiring an additional 100 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its holdings in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after acquiring an additional 115 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Encompass Health by 10.9% during the second quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock valued at $146,000 after acquiring an additional 117 shares in the last quarter. Finally, Exchange Traded Concepts LLC increased its holdings in shares of Encompass Health by 1.9% during the second quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company’s stock valued at $993,000 after acquiring an additional 152 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

EHC has been the subject of several recent research reports. Truist Financial boosted their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a report on Thursday, August 14th. Weiss Ratings reiterated a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. UBS Group upped their price target on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Barclays upped their price target on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a report on Thursday. Finally, Bank of America upped their price target on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating and eight have given a Buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $142.86.

Encompass Health Stock Down 2.5%

Shares of NYSE:EHC opened at $113.86 on Friday. The company has a market capitalization of $11.47 billion, a PE ratio of 21.52, a price-to-earnings-growth ratio of 2.20 and a beta of 0.93. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The business has a fifty day moving average price of $124.22 and a two-hundred day moving average price of $118.88. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. The firm had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Analysts forecast that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio is 14.37%.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the company’s stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. This represents a 5.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.